$M
Macy's, Inc. Stock $m

$m Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024025853 Filed on May 30, 2024

Income Statement

Concept	2024 Q2
Revenue	$5.000B
YoY Change	-3.34%
Cost Of Revenue	$2.946B
YoY Change	-1.41%
Gross Profit	$2.054B
YoY Change	-6.0%
Gross Profit Margin	41.08%
Selling, General & Admin	$1.911B
YoY Change	-2.0%
% of Gross Profit	93.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$216.0M
YoY Change	-0.92%
% of Gross Profit	10.52%
Operating Expenses	$1.911B
YoY Change	-2.0%
Operating Profit	$143.0M
YoY Change	-39.15%
Interest Expense	-$31.00M
YoY Change	-16.22%
% of Operating Profit	-21.68%
Other Income/Expense, Net	$4.000M
YoY Change	0.0%
Pretax Income	$98.00M
YoY Change	-53.55%
Income Tax	$36.00M
% Of Pretax Income	36.73%
Net Earnings	$62.00M
YoY Change	-60.0%
Net Earnings / Revenue	1.24%
Basic Earnings Per Share	$0.22
Diluted Earnings Per Share	$0.22
COMMON SHARES
Basic Shares Outstanding	276.1M shares
Diluted Shares Outstanding	281.0M shares

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$876.0M
YoY Change	45.27%
Cash & Equivalents	$876.0M
Short-Term Investments
Other Short-Term Assets	$442.0M
YoY Change	13.33%
Inventory	$4.687B
Prepaid Expenses	$442.0M
Receivables	$257.0M
Other Receivables	$0.00
Total Short-Term Assets	$6.262B
YoY Change	6.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.653B
YoY Change	-10.79%
Goodwill	$828.0M
YoY Change	0.0%
Intangibles	$429.0M
YoY Change	-0.69%
Long-Term Investments
YoY Change
Other Assets	$1.277B
YoY Change	8.77%
Total Long-Term Assets	$10.19B
YoY Change	-7.5%
TOTAL ASSETS
Total Short-Term Assets	$6.262B
Total Long-Term Assets	$10.19B
Total Assets	$16.45B
YoY Change	-2.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.435B
YoY Change	-4.58%
Accrued Expenses	$2.088B
YoY Change	-6.49%
Deferred Revenue	$349.0M
YoY Change	-3.06%
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.550B
YoY Change	-4.85%
LONG-TERM LIABILITIES
Long-Term Debt	$2.998B
YoY Change	0.07%
Other Long-Term Liabilities	$3.966B
YoY Change	-0.95%
Total Long-Term Liabilities	$6.964B
YoY Change	-0.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.550B
Total Long-Term Liabilities	$6.964B
Total Liabilities	$12.26B
YoY Change	-3.43%
SHAREHOLDERS EQUITY
Retained Earnings	$6.125B
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.186B
YoY Change
Total Liabilities & Shareholders Equity	$16.45B
YoY Change	-2.48%

Cashflow Statement

Concept	2024 Q2
OPERATING ACTIVITIES
Net Income	$62.00M
YoY Change	-60.0%
Depreciation, Depletion And Amortization	$216.0M
YoY Change	-0.92%
Cash From Operating Activities	$129.0M
YoY Change	22.86%
INVESTING ACTIVITIES
Capital Expenditures	$229.0M
YoY Change	-22.64%
Acquisitions
YoY Change
Other Investing Activities	$12.00M
YoY Change	-53.85%
Cash From Investing Activities	-$217.0M
YoY Change	-19.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-70.00M
YoY Change	-25.53%
NET CHANGE
Cash From Operating Activities	129.0M
Cash From Investing Activities	-217.0M
Cash From Financing Activities	-70.00M
Net Change In Cash	-158.0M
YoY Change	-39.0%
FREE CASH FLOW
Cash From Operating Activities	$129.0M
Capital Expenditures	$229.0M
Free Cash Flow	-$100.0M
YoY Change	-47.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2024Q2	us-gaap	Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2023Q2	us-gaap	Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2024Q2	m	Other Revenue Net OtherRevenueNet	154000000	usd
CY2023Q2	m	Other Revenue Net OtherRevenueNet	191000000	usd
CY2024Q2	us-gaap	Revenues Revenues	5000000000	usd
CY2023Q2	us-gaap	Revenues Revenues	5173000000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2946000000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2988000000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1911000000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1950000000	usd
CY2024Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	11000000	usd
CY2024Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	19000000	usd
CY2023Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	2000000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	125000000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	244000000	usd
CY2024Q2	m	Defined Benefit Plan Net Periodic Benefit Income Net DefinedBenefitPlanNetPeriodicBenefitIncomeNet	4000000	usd
CY2023Q2	m	Defined Benefit Plan Net Periodic Benefit Income Net DefinedBenefitPlanNetPeriodicBenefitIncomeNet	4000000	usd
CY2024Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-31000000	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-37000000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	98000000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	211000000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36000000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	62000000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	155000000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	62000000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	155000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax	1000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax	2000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	62000000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	156000000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	876000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1034000000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	603000000	usd
CY2024Q2	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	257000000	usd
CY2024Q1	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	293000000	usd
CY2023Q2	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	255000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	4687000000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	4361000000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	4607000000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	442000000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	401000000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	390000000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	6262000000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6089000000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	5855000000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4410000000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4276000000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4763000000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5295000000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5308000000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5864000000	usd
CY2024Q2	m	Lease Right Of Use Asset LeaseRightOfUseAsset	2358000000	usd
CY2024Q1	m	Lease Right Of Use Asset LeaseRightOfUseAsset	2305000000	usd
CY2023Q2	m	Lease Right Of Use Asset LeaseRightOfUseAsset	2715000000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	828000000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	828000000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	828000000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	429000000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	430000000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	432000000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1277000000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1286000000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1174000000	usd
CY2024Q2	us-gaap	Assets Assets	16449000000	usd
CY2024Q1	us-gaap	Assets Assets	16246000000	usd
CY2023Q2	us-gaap	Assets Assets	16868000000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2347000000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1913000000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2415000000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2088000000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2434000000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2233000000	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	115000000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	83000000	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	134000000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4550000000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4430000000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4782000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2998000000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2998000000	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2996000000	usd
CY2024Q2	m	Noncurrent Lease Liability NoncurrentLeaseLiability	3034000000	usd
CY2024Q1	m	Noncurrent Lease Liability NoncurrentLeaseLiability	2986000000	usd
CY2023Q2	m	Noncurrent Lease Liability NoncurrentLeaseLiability	2996000000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	749000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	745000000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	916000000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	932000000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	950000000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1008000000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	4186000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	4137000000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4170000000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16449000000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16246000000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16868000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	4137000000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	62000000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.1737
CY2024Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	48000000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13000000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1000000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	4186000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4082000000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	155000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.1654
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	45000000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	25000000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14000000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-12000000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4170000000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	62000000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	155000000	usd
CY2024Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	19000000	usd
CY2023Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	2000000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	216000000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	218000000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	13000000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	14000000	usd
CY2024Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	11000000	usd
CY2024Q2	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	1000000	usd
CY2023Q2	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	2000000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3000000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3000000	usd
CY2024Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-10000000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-32000000	usd
CY2024Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-35000000	usd
CY2023Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-45000000	usd
CY2024Q2	us-gaap	Increase Decrease In Retail Related Inventories IncreaseDecreaseInRetailRelatedInventories	273000000	usd
CY2023Q2	us-gaap	Increase Decrease In Retail Related Inventories IncreaseDecreaseInRetailRelatedInventories	340000000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	49000000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-32000000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	401000000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	374000000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-289000000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-415000000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	34000000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	82000000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	33000000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	24000000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	129000000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	105000000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	154000000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	215000000	usd
CY2024Q2	us-gaap	Payments For Software PaymentsForSoftware	75000000	usd
CY2023Q2	us-gaap	Payments For Software PaymentsForSoftware	81000000	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4000000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	25000000	usd
CY2024Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-8000000	usd
CY2023Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1000000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-217000000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-270000000	usd
CY2024Q2	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	1000000	usd
CY2023Q2	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	1000000	usd
CY2024Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	48000000	usd
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	45000000	usd
CY2024Q2	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	-21000000	usd
CY2023Q2	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	-13000000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	35000000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-70000000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-94000000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-158000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-259000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1037000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	865000000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	879000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	606000000	usd
CY2024Q2	us-gaap	Interest Paid Net InterestPaidNet	59000000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	60000000	usd
CY2024Q2	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	12000000	usd
CY2023Q2	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	11000000	usd
CY2024Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12000000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6000000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3000000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3000000	usd
CY2024Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	43	state
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates and assumptions are subject to inherent uncertainties which may result in actual amounts differing from reported amounts.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Consolidated Financial Statements for the 13 weeks ended May 4, 2024 and April 29, 2023, in the opinion of management, include all adjustments (consisting only of normal recurring adjustments) considered necessary to present fairly, in all material respects, the consolidated financial position and results of operations of the Company.</span></div>
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	62000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	275200000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	272200000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	900000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	900000	shares
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	62000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	276100000	shares
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	155000000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	273100000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4900000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4700000	shares
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	62000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	281000000.0	shares
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	155000000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	277800000	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2024Q2	m	Percentage Of Net Sales To Total Revenue PercentageOfNetSalesToTotalRevenue	0.97
CY2023Q2	m	Percentage Of Net Sales To Total Revenue PercentageOfNetSalesToTotalRevenue	0.96
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4846000000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4982000000	usd
CY2024Q2	m	Other Revenue Net OtherRevenueNet	154000000	usd
CY2023Q2	m	Other Revenue Net OtherRevenueNet	191000000	usd
CY2024Q2	us-gaap	Revenues Revenues	5000000000	usd
CY2023Q2	us-gaap	Revenues Revenues	5173000000	usd
CY2024Q2	m	Macys Sales To Entire Company Sales MacysSalesToEntireCompanySales	0.84
CY2023Q2	m	Macys Sales To Entire Company Sales MacysSalesToEntireCompanySales	0.85
CY2024Q2	m	Percentage Of Digital Sales To Net Sales PercentageOfDigitalSalesToNetSales	0.32
CY2023Q2	m	Percentage Of Digital Sales To Net Sales PercentageOfDigitalSalesToNetSales	0.32
CY2024Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	193000000	usd
CY2024Q1	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	136000000	usd
CY2023Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	214000000	usd
CY2024Q2	us-gaap	Contract With Customer Right To Recover Product ContractWithCustomerRightToRecoverProduct	116000000	usd
CY2024Q1	us-gaap	Contract With Customer Right To Recover Product ContractWithCustomerRightToRecoverProduct	83000000	usd
CY2023Q2	us-gaap	Contract With Customer Right To Recover Product ContractWithCustomerRightToRecoverProduct	127000000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	349000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	384000000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	360000000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3007000000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	2996000000	usd
CY2023Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	2468000000	usd
CY2024Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2023Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1400000	shares
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	25000000	usd
CY2024Q2	m	Number Of Hours Required For Participation In Defined Benefit And Defined Contribution Plans NumberOfHoursRequiredForParticipationInDefinedBenefitAndDefinedContributionPlans	1000	hour
CY2024Q2	m	Total Retirement Expense TotalRetirementExpense	20000000	usd
CY2023Q2	m	Total Retirement Expense TotalRetirementExpense	20000000	usd
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	36000000	usd
CY2024Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	42000000	usd
CY2023Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	36000000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3007000000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	2998000000	usd
CY2024Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	2766000000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3007000000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	2998000000	usd
CY2024Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	2706000000	usd
CY2024Q2	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	125000000	usd
CY2024Q1	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	112000000	usd
CY2023Q2	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	102000000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-025853-index-headers.html	Edgar Link	pending
0001628280-24-025853-index.html	Edgar Link	pending
0001628280-24-025853.txt	Edgar Link	pending
0001628280-24-025853-xbrl.zip	Edgar Link	pending
a2024performancebasedrsuce.htm	Edgar Link	pending
a2024performancebasedrsuex.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
m-20240504.htm	Edgar Link	pending
m-20240504.xsd	Edgar Link	pending
m-20240504x10qxexx311.htm	Edgar Link	pending
m-20240504x10qxexx312.htm	Edgar Link	pending
m-20240504x10qxexx321.htm	Edgar Link	pending
m-20240504x10qxexx322.htm	Edgar Link	pending
m-20240504_g1.gif	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
preferabilityletterex18.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
m-20240504_lab.xml	Edgar Link	unprocessable
m-20240504_pre.xml	Edgar Link	unprocessable
m-20240504_htm.xml	Edgar Link	completed
m-20240504_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
m-20240504_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$M
Macy's, Inc. Stock $m

2024 Q2 Form 10-Q Financial Statement

#000162828024025853 Filed on May 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$M Macy's, Inc. Stock $m

2024 Q2 Form 10-Q Financial Statement

#000162828024025853 Filed on May 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$M
Macy's, Inc. Stock $m